KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Current Assets (2016 - 2025)

Sarepta Therapeutics has reported Current Assets over the past 15 years, most recently at $2.5 billion for Q4 2025.

  • Quarterly results put Current Assets at $2.5 billion for Q4 2025, down 17.42% from a year ago — trailing twelve months through Dec 2025 was $2.5 billion (down 17.42% YoY), and the annual figure for FY2025 was $2.5 billion, down 17.42%.
  • Current Assets for Q4 2025 was $2.5 billion at Sarepta Therapeutics, down from $2.7 billion in the prior quarter.
  • Over the last five years, Current Assets for SRPT hit a ceiling of $3.1 billion in Q4 2024 and a floor of $2.2 billion in Q3 2021.
  • Median Current Assets over the past 5 years was $2.5 billion (2022), compared with a mean of $2.5 billion.
  • Biggest five-year swings in Current Assets: increased 20.16% in 2022 and later decreased 17.42% in 2025.
  • Sarepta Therapeutics' Current Assets stood at $2.6 billion in 2021, then decreased by 1.78% to $2.6 billion in 2022, then increased by 0.84% to $2.6 billion in 2023, then grew by 19.16% to $3.1 billion in 2024, then dropped by 17.42% to $2.5 billion in 2025.
  • The last three reported values for Current Assets were $2.5 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.7 billion (Q2 2025) per Business Quant data.